Relevium Technologies Inc. (V:RLV.H)

Business Focus: Special Foods & Wellbeing Products

Get the company report for the most recent outlook updated daily

Aug 09, 2022 02:07 pm ET

Relevium Announces Change in Auditors

RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its board of directors (the “Board”) has approved a change of the Company’s auditor. The Board has appointed...

Apr 21, 2022 08:22 pm ET

Relevium Provides Operational and Continued Disclosure Update

RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on operations and continuous disclosure matters. UPDATE ON ONGOING OPERATIONS On December 16,...

Feb 11, 2022 04:55 pm ET

Relevium Provides Operational and Continued Disclosure Update

Jan 10, 2022 07:00 am ET

IIROC Trading Halt - RLV

VANCOUVER, BC, Jan. 10, 2022 /CNW/ - The following issues have been halted by IIROC:

Jan 05, 2022 01:13 pm ET

Relevium Provides Bi-Weekly Update to Management Cease Trade Order

Relevium Technologies Inc. (the “Company” or “Relevium”) (TSXV: RLV) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on November 1, 2021, in respect of the audited annual financial statements and...

Dec 18, 2021 02:13 pm ET

Relevium Provides Bi-Weekly Update to Management Cease Trade Order and Shares for Debt Settlement

Dec 16, 2021 10:25 am ET

Relevium Secures Two PPE Contracts Totaling $16 Million; Contracts Result in Record Revenues and Earnings for Q2 and for FYE June 30, 2022

RELEVIUM TECHNOLOGIES INC. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that in the month of December it secured two PPE contracts valued at CAD$11million and CAD$5 million...

Nov 30, 2021 11:35 am ET

Relevium Provides Update to Management Cease Trade Order and Other Matters

Nov 23, 2021 08:54 am ET

Relevium Significantly Strengthens its JV Operations by Entering Into an Agreement to Acquire 100% of Terry Booth’s MED PPE CANADA

RELEVIUM TECHNOLOGIES INC. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), a company operating in the Personal Protective Equipment (“PPE) sector, is pleased to announce today it has entered into a non-binding term...

Nov 19, 2021 09:11 am ET

Relevium Provides Update to Management Cease Trade Order and Other Matters

Nov 01, 2021 06:14 pm ET

Relevium Announces Delay in Filing Annual Financial Statements

Relevium Technologies Inc. (TSX-V : RLV, OTC : RLLVF, and Frankfurt : 6BX) (the “Company” or “Relevium”) announces that its annual financial statements for the year ended June 30, 2021, including the related management discussion and analysis, and...

Oct 01, 2021 02:47 pm ET

Relevium Technologies Completes Shares-For-Debt Transactions

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has completed its previously announced shares-for-debt settlements pursuant to which the Company has settled...

Aug 10, 2021 09:48 am ET

Relevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in Shares

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has received conditional approval from the TSX Venture Exchange for the settlement in shares of the outstanding notes...

Jun 30, 2021 11:19 am ET

Relevium Announces Settlement of the Outstanding Notes

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today it has reached an agreement to settle the outstanding notes totalling $2,798,550. SETTLEMENT DETAILS OF THE OUTSTANDING...

Jun 15, 2021 10:11 am ET

Relevium Announces Shareholder Townhall and Conference Call

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders, partners, affiliates and interested parties to attend a “TOWN HALL” Investor Relations conference...

Jun 10, 2021 08:58 am ET

IIROC Trading Resumption - RLV

VANCOUVER, BC, June 10, 2021 /CNW/ - Trading resumes in:

Jun 10, 2021 08:11 am ET

Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today the maturity of its outstanding convertible debenture notes and that it has begun the process of negotiating their...

Jun 02, 2021 09:32 am ET

IIROC Trading Halt - RLV

VANCOUVER, BC, June 2, 2021 /CNW/ - The following issues have been halted by IIROC:

May 20, 2021 02:00 am ET

Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix Health Corporation (the “BCX”), a company focused on international research and development...

May 05, 2021 09:47 am ET

Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), whose primary mandate is to focus on international procurement, logistics, and delivery of Personal Protective Equipment (“PPE) and wellness...

Apr 29, 2021 09:12 am ET

Biocannabix Enters Into LOI With IAM Health GmbH

Mar 11, 2021 01:59 pm ET

Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has secured delivery of the delivery of first production batch Personal Protective Equipment (“PPE”) from...

Feb 04, 2021 04:47 pm ET

Relevium Announces Investor Relations Conference Call

Jan 25, 2021 09:42 am ET

Relevium Reports Interim First Quarter Results for the Three-Month Period Ended September 30, 2020

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the interim financial statements and MD&A for the three-month period ended September 30, 2020. The...

Jan 20, 2021 07:10 am ET

Relevium Reports Fiscal Year Ended June 30, 2020 Results

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the financial audit for the fiscal year ended June 30, 2020. The Company’s overall performance for...

Jan 06, 2021 05:58 pm ET

Relevium Issues Corporate Update on MCTO and Filing of Financial Statements

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces an update on its ongoing disclosure obligations and to its previously disclosed management cease trade order ("MCTO"), announced on...

Dec 18, 2020 09:17 pm ET

Relevium Issues Corporate Update on MCTO and Filing of Financial Statements

Dec 03, 2020 08:18 pm ET

Relevium Issues Corporate Update on MCTO and Operations

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide an update on all major corporate initiatives and ongoing disclosure obligations. UPDATE ON THE FILING OF AUDITED...

Nov 30, 2020 06:51 pm ET

Relevium Provides Regulatory Update on Annual Financials and Management Cease Trade Order

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is providing an update to its previously disclosed management cease trade order ("MCTO"), announced on October 27, 2020, in respect of the...

Nov 11, 2020 05:28 pm ET

Relevium Provides Update to Management Cease Trade Order

Oct 27, 2020 06:12 pm ET

Relevium Announces Delay in Filing Annual Audited Financial Statements

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces that its annual financial statements for the year ended June 30, 2020, including the related management discussion and analysis,...

Oct 19, 2020 08:00 am ET

Relevium Resumes Shipments for Overseas Contract and Delivers CAD $215,000 in Formulated Products to Saudi Arabia

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD $215,000 worth of generic...

Sep 29, 2020 08:14 am ET

Relevium’s BGX E-Health Begins Delivery of US$16.9M of Its Initial PPE Contract via Air Freight Charters

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that its wholly-owned subsidiary in the US, BGX E-Health LLC ( “BGX”), has secured up to eight chartered flights to...

Sep 17, 2020 02:52 pm ET

IIROC Trading Resumption - RLV

VANCOUVER, BC, Sept. 17, 2020 /CNW/ - Trading resumes in:

Sep 17, 2020 02:08 pm ET

Relevium’s BGX E-Health Secures US$20M Contract for Supplying PPE to the Canadian Market for Q1 of the Current Fiscal Year

Sep 17, 2020 08:03 am ET

IIROC Trading Halt - RLV

VANCOUVER, BC, Sept. 17, 2020 /CNW/ - The following issues have been halted by IIROC:

Aug 04, 2020 10:16 am ET

Relevium Licenses Patented Science-Based Natural Formulation That Addresses Major Points of Viral Invasion, Replication and Toxicities

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has secured licenced a patented science based nutraceutical formulation that addresses major points of viral...

Jul 21, 2020 01:19 pm ET

Relevium Launches CleanCare Products on the Amazon.com Platform

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that the company has successfully launched its new CleanCare Hand Sanitizer product by Bioganix on Amazon.com. The...

Jul 16, 2020 05:12 pm ET

Relevium Reports Significant Improvement on its Net Loss as the Company Restructures Product Lines and Cost Structures During the Three and Nine-Month Period Ended March 31, 2020

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report third quarter results for fiscal year ending June 30, 2020. During the three-month period ended March 31, 2020,...

Jul 13, 2020 10:41 pm ET

Relevium Technologies and H-Source Holdings Partner for the Strategic Development and Global Supply of Personal Protective Equipment

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has entered into a Letter of Intent (“LOI”) with H-Source Holdings, a leading secure and trusted Personal...

Jul 13, 2020 01:41 pm ET

Relevium Announces CleanCare Expansion into Disinfection and Personal Protection and Appoints the PaperStore as Official Retailer for Northeast USA

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company’s expansion of its Bioganix CleanCare brand into the Disinfection and Personal Protection Market...

Jul 06, 2020 07:27 pm ET

Relevium Provides Regulatory Update Pursuant to Temporary Relief Granted by Regulators Due to COVID-19

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide a regulatory update pursuant to the temporary relief granted by regulators due to COVID-19. On June 2, 2020 The...

Jun 23, 2020 03:49 pm ET

Relevium Issues Important Clarification About Bioganix CleanCare Brand

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an important clarification about Bioganix CleanCare, its brand of disinfection and wellness products. On. June 19,...

Jun 23, 2020 09:15 am ET

Relevium Welcomes Award-Winning Marketing Executive to Its Advisory Board

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the appointment of Mr. James Mansour, an award-winning brand and marketing executive to its advisory board. Mr....

Jun 19, 2020 12:19 pm ET

Relevium Expands CleanCare Offering as International Organizations Call for Increased Institutional and Government Stockpile of Supplies

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has expanded and continues to expand its CleanCare™ product line as it prepares to address increased government...

Jun 11, 2020 01:45 pm ET

Relevium Successfully Delivers Initial Orders of Cleancare™ Products to Retail Customers

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the successful delivery of Cleancare™ Hand Sanitizers to retail customers in the in the US, including the orders...

Jun 02, 2020 11:12 am ET

Relevium Provides Regulatory Update on Previously Announced Initiatives and Transactions

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), as a requirement in order to obtain final regulatory approval for its private placement as announced on Monday May 25, 2020, is pleased to...

May 27, 2020 05:11 pm ET

Relevium Announces Delayed Filing of Interim Disclosure Documents Pursuant to Temporary Relief Granted by Regulators due to COVID-19

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), today announced that it will be delaying the filing and delivery of certain of its continuous disclosure documents, in accordance with...

May 25, 2020 03:50 pm ET

Relevium Announces $1.8M Private Placement and Closing

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce today a private placement offering of up to 58,000,000 units (the “Units”) of the Company at a price of $0.035 per...

Apr 24, 2020 11:45 am ET

Relevium Expands CleanCare™ Hand Sanitizer Formats and Supply Capabilities; Company Targets Retirement Homes and Community Centers

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that its expanding its CleanCare™ hand sanitizing line to include two new retail formats as well as one new...

Apr 20, 2020 12:00 pm ET

Relevium to Present at Mi3 Online Investor Webinar

Relevium Technologies Inc. (TSX.V:“RLV”, OTC:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company will be presenting at the Mi3 Investor and Broker Video Conference this Friday April 24th at 12:00PM...

Apr 15, 2020 10:28 am ET

Relevium Reports $250,000 in Pre-Sales for Bioganix® CleanCare Hand Sanitizers in First 6 Days

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that its new line of Bioganix® CleanCare hand sanitizers has been met with very strong pre-sales demand of...

Apr 13, 2020 10:32 am ET

RELEVIUM TO LAUNCH PHOTOCATALYTIC UV AIR PURIFICATION SYSTEM FOR BIOGANIX® CLEANCARE LINE

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today it has partnered with Montreal based air purification leaders to launch a new line of residential and office...

Apr 09, 2020 12:36 pm ET

RELEVIUM LAUNCHES PRE-ORDER OF BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA AND USA

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company has launched its newly launched Bioganix® CleanCare hand sanitizer product on pre-order to consumers...

Apr 08, 2020 03:44 pm ET

RELEVIUM TO PRESENT AT Mi3 ONLINE INVESTOR WEBINAR

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company will be presenting at the Mi3 Investor and Broker Video Conference this Friday April 10th at 1:30PM...

Apr 08, 2020 11:02 am ET

RELEVIUM SECURES NPN NUMBER WITH MANUFACTURING PARTNER AND IS READY TO MARKET BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has secured the natural product number (“NPN”) for the Canadian market and is ready to launch the product for...

Apr 06, 2020 11:03 am ET

Relevium Launches Pre-Order of Bioganix® Cleancare Hand Sanitizers

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that a pre-order platform where customers can purchase in advance and reserve its new line of Cleancare hand...

Apr 02, 2020 11:01 am ET

RELEVIUM TO COMMERCIALIZE BIOGANIX® CLEANCARE HAND SANITIZERS

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today it has sourced and will begin commercializing a line of Bioganix® hand sanitizers. Relevium is leveraging...

Mar 04, 2020 11:40 am ET

Relevium Announces the Passing of Dr. Tina Sampalis, Director and Scientific Officer

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is announces the passing of Dr. Tina Sampalis, Director and Scientific Officer of the Company. It is with heavy hearts and great sadness...

Mar 03, 2020 11:45 am ET

Relevium Ships First Purchase Order Release of $130,000 to Middle East Customer

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD $130,000 worth of generic...

Mar 02, 2020 08:30 am ET

Relevium Reports Improved Financial Results for Second Quarter of Fiscal 2020

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results for fiscal year ending June 30, 2020. Financial highlights for the second quarter of 2020...

Feb 05, 2020 08:10 am ET

Relevium Announces Update Call for Shareholders

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce a shareholder information video-conference call to provide an update on the current business and ongoing...

Jan 28, 2020 09:15 am ET

Relevium Provides Update on Newscope Transacion

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on the proposed transaction with Newscope Capital. As announced in a letter from the CEO issued on...

Dec 19, 2019 09:14 am ET

Relevium’s CEO Provides an Open Shareholder Letter for 2020

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio Useche. Dear valued...

Nov 20, 2019 09:18 am ET

Relevium Launches LeefyLyfe™ Organic Hemp Products in the US

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness products formulated with...

Nov 08, 2019 08:35 am ET

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract manufacturing company through its...

Nov 07, 2019 09:11 am ET

Relevium Technologies Appoints Mark Billings as Chief Financial Officer

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the appointment of Mark Billings, CFA as Chief Financial Officer for both Relevium and Biocannabix Health...

Oct 30, 2019 09:30 am ET

Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary, BGX E-Health LLC (“BGX”), has received a purchase order to supply Innova Health...

Oct 29, 2019 09:22 am ET

Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019, the Company received a letter of intent (the “LOI”) to roll its interest in its wholly owned...

Oct 17, 2019 08:30 am ET

Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly- owned subsidiary, Biocannabix (“BCX”), has executed an Agreement (the “Agreement”) to acquire 100% of...

Oct 09, 2019 03:05 pm ET

Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that it has registered four hundred (400) Natural Product Numbers (NPNs) with Health Canada through its main...

Sep 19, 2019 08:34 am ET

Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new, publicly-traded company through a spin-out of its pediatric, medical cannabis subsidiary,...

Sep 11, 2019 09:18 am ET

Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the Company's annual general and special meeting (the "AGM") held on September 6, 2019, in Montreal,...

Aug 01, 2019 09:41 am ET

Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high in monthly sales in the month of July 2019 for its Bioganix® branded OTC...

Jul 10, 2019 09:30 am ET

Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric...

Jul 03, 2019 10:03 am ET

Relevium’s CEO Issues Letter of Clarification to Shareholders

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today a letter from Aurelio Useche, CEO to shareholders to clarify misconceptions and rumours in the market about a compliance...

Jul 01, 2019 04:24 pm ET

Relevium Issues Statement Regarding Recent Promotional Activity

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent promotional activity...

Jun 26, 2019 04:00 am ET

Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”) announced today it is positioning itself as an important player in the Colombian medical...

Jun 19, 2019 08:30 am ET

Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST

Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”), is pleased to announce it will be holding a shareholder and investor conference call to...

Jun 13, 2019 01:04 pm ET

IIROC Trading Resumption - RLV

VANCOUVER, June 13, 2019 /CNW/ - Trading resumes in:

Jun 13, 2019 09:54 am ET

Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12,...

Jun 13, 2019 08:28 am ET

IIROC Trading Halt - RLV

VANCOUVER, June 13, 2019 /CNW/ - The following issues have been halted by IIROC:

Jun 11, 2019 05:51 pm ET

Relevium Closes Private Placement Financing

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of 15,350,000 units (the "Units") at...

Jun 05, 2019 09:46 am ET

Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned subsidiary Biocannabix Health Corporation (“Biocannabix”) has executed an LOI to acquire 30% of...

Jun 03, 2019 11:31 am ET

Relevium Provides Corporate Update on Its Medical Cannabis Strategy

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis and CBD Nutraceuticals....

May 30, 2019 08:00 am ET

Relevium Acquires Exclusive Licence From California Based Cannakids®

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed necessary compliance process and...

May 24, 2019 09:29 am ET

Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a new line of omega fish oils based formulations targeting inflammation, heart and...

May 21, 2019 10:24 am ET

IIROC Trading Resumption - RLV

VANCOUVER, May 21, 2019 /CNW/ - Trading resumes in:

May 21, 2019 08:30 am ET

Relevium Announces Private Share Purchase by CEO

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that Mr. Aurelio Useche, Chief Executive Officer, has agreed to purchase a total of 4,213,713 common shares of Relevium,...

May 21, 2019 08:28 am ET

IIROC Trading Halt - RLV

VANCOUVER, May 21, 2019 /CNW/ - The following issues have been halted by IIROC:

May 21, 2019 07:05 am ET

Albertus P. Engelbrecht Files Early Warning Report

MONTREAL, QUEBEC / TheNewswire / May 21, 2019 – Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with the disposition of 4,213,713 common shares in the capital of Relevium Technologies Inc. (the "Issuer"). The shares were disposed of on May 21, 2019 through a private sale between the Shareholder and the Issuer’s Chief Executive Officer, Mr. Aurelio Useche, for an amount of CAD$547,782, equivalent to CAD$0.13 per common share.

May 17, 2019 09:27 am ET

Relevium Announces Reprice of the 2016 and 2017 Series Warrants

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced the re-pricing 12,398,500 warrants series 2017 with an original exercise price of $0.15 and expiring June 16, 2019 and 3,258,000...

Mar 01, 2019 08:53 am ET

Relevium Reports Second Quarter Revenue Bounce Back for Fiscal 2019

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results for fiscal 2019. Financial highlights for the second quarter of 2019 During the second...

Feb 13, 2019 08:00 am ET

Walmart’s Influence in the Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending

Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at increased quarterly sales for the sector thanks, in no small part, to Walmart. CNBC has reported on how Walmart is looking...

Feb 08, 2019 02:42 pm ET

Relevium Announces DTC Eligibility for the US Market

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC. DTC is a subsidiary of...

Feb 07, 2019 08:31 am ET

Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the Push and Pull System™, an innovation in delivering a comprehensive solution for skin care,...

Jan 29, 2019 10:01 am ET

Relevium Announces Investor Web Conference

Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it will be hosting a town hall webcast on February 8th 2019 after market hours at 16:30 EST to discuss the...

Jan 23, 2019 08:30 am ET

Relevium to Acquire Multi-Brand Company in the UK

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a binding agreement to acquire 100% of the shares of Sleipnir Nutrition Ltd. (“Sleipnir”), a UK...

Jan 15, 2019 02:13 pm ET

Relevium To Host Screenings of Documentary “Weed The People” Across Canada Today -- CFN Media

via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF”...

Jan 10, 2019 03:38 pm ET

Relevium Announces the National Screening of “Weed the People” Movie Across Eight Major Cities

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the national screening of “Weed the People” across eight Canadian cities on January 15, 2019. Relevium Technologies,...

Jan 03, 2019 11:01 am ET

Clarification: Albertus P. Engelbrecht Files Early Warning Report

MONTREAL, QUEBEC / TheNewswire / January 3, 2019 - Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with his holdings in the capital of Relevium Technologies Inc. (the "Issuer").

Jan 03, 2019 07:01 am ET

Albertus P. Engelbrecht Files Early Warning Report

MONTREAL, QUEBEC / TheNewswire / January 3, 2019 – Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with his holdings in the capital of Relevium Technologies Inc. (the "Issuer").

Dec 13, 2018 04:49 pm ET

Relevium Provides Corporate Update

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide shareholders with a corporate update on the previously announced transaction with CannaKids and CK properties, as well...

Dec 13, 2018 09:48 am ET

Relevium Launches Its Leefylyfe™ Organically Sourced Whole Plant Hemp Derived CBD Products in the UK

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has launched its Leefylyfe™ brand of organically sourced full spectrum hemp CBD products on a pre-order...

Dec 12, 2018 09:41 am ET

Relevium Launches 30 New Bioganix® Gold Brand Products in Walmart.com

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has launched 30 new exclusive products under its Bioganix® Gold Brand in Walmart.com On October 11, 2018,...

Dec 05, 2018 09:00 am ET

Relevium Adds Amazon Experts to the Team

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has retained Rohan Mendonza and his company, NForce Labs Inc., to lead its Amazon business. Rohan Mendonza,...

Nov 30, 2018 09:41 am ET

Relevium Technologies Provides Corporate Update and Summarized First Quarter Results

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update and summarized discussion on the results for its first quarter. Cannakids License for Canada...

Nov 15, 2018 02:07 pm ET

Relevium Technologies Signs JV With Holistic Industries for Biocannabix Health Corporation

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has executed a letter of intent to form a partnership with Holistic Industries to jointly develop Biocannabix...

Oct 29, 2018 09:32 am ET

Relevium Technologies Provides Corporate Update and Fiscal Year End Results

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide a corporate update and summarized discussion on the results for its first year of operations since the acquisition of...

Oct 26, 2018 09:40 am ET

Relevium Technologies Announces Conversion of Debentures and Strenghtens Balance Sheet

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has received notices to convert (the "Conversion") all of the principal amount outstanding of the remaining...

Oct 16, 2018 08:30 am ET

Relevium Announces Strategic Investment in Leading Pediatric Cannabis Company and Obtains Exclusive License for the Canadian Market

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has executed a binding letter of intent for a strategic investment into CannaKids.org for an initial 25%...

Oct 11, 2018 09:46 am ET

Relevium Targets 30 New Bioganix® Gold Products in Walmart by Year End and Prepares to Launch in Canada

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced its plans to increase its presence in Walmart.com and ramp up its current offering to over thirty (30) SKUs before the end of...

Oct 02, 2018 11:38 am ET

At the Request of IIROC Relevium Unaware of Any Material Changes

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), at the request of IIROC (Investment Industry Regulatory Organization of Canada) wishes to confirm that the Company’s management is unaware...

Sep 20, 2018 09:20 am ET

Relevium’s Bioganix® Now Live on Amazon.co.uk

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom (“UK”) on the Amazon.co.uk platform....

Sep 18, 2018 08:35 am ET

Relevium Set to Launch Organic Hemp CBD Product Line in the Fall

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it will be launching its first organic whole hemp extract product line under the LeefyLyfe® brand in Europe...

Sep 05, 2018 08:33 am ET

Relevium’s Biocannabix Subsidiary Signs Lease Agreement for Its ACMPR Facility

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company’s wholly owned subsidiary Biocannabix (“BCX”) has signed a lease agreement for the company’s...

Aug 21, 2018 08:00 am ET

Relevium Launches 5 New Bioganix® Products

Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company has just launched five new Bioganix® products which are now live on both the native websites at...

Jul 30, 2018 08:45 am ET

Relevium’s Bioganix® Gold Series Nutraceuticals Live on Walmart.com

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are...

Jul 19, 2018 08:00 am ET

Relevium’s Biocannabix Receives City Approval for Medical Cannabis Facility

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that the company’s wholly owned subsidiary Biocannabix Health Corporation (“BCX”) has received an approval letter from...

Jul 05, 2018 08:00 am ET

Relevium Secures CBD Supply Agreement for European Market

Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has executed a supply agreement with Plena Global Holdings Inc., a Canadian based holding company accumulating medical...

Jun 15, 2018 11:37 am ET

Relevium Starts Production of Two Exclusive Formulations With Patented Provinal® Omega 7

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has put into production 920,000 soft-gels each of its Cardio-Metabolic Syndrome and Dry-Eye Syndrome formulations...

Jun 08, 2018 08:17 am ET

Relevium Reduces Liabilities by $2 Million Through Conversion of Debenture Well Ahead of Maturity

Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the reduction of CAD $2 million in debt through the conversion (the “Conversion”) of the entire principal amount of USD...

Jun 08, 2018 07:06 am ET

Albertus P. Engelbrecht Files Early Warning Report

MONTREAL, QUEBEC / TheNewswire / June 8, 2018 – Pursuant to the terms of the convertible note between Relevium Technologies Inc. (the “Issuer”) and Mr. Albertus P. Engelbrecht, completed on June 8, 2018 (the “Closing Date”), Mr. Engelbrecht has acquired direct ownership (the “Acquisition”) of an aggregate of 14,587,688 common shares (the “Acquired Shares”) in the capital of Relevium Technologies Inc. (the “Issuer”).

Jun 04, 2018 09:13 am ET

Relevium Selects 93,000 Sq. Ft Organic Cultivation Facility in Quebec

Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that, through its wholly-owned subsidiary Biocannabix (“BCX”), it has selected a 93,000 square foot facility in Montreal,...

May 30, 2018 12:19 pm ET

Relevium Announces Revenue of $3.2M for the Nine-Month Period Ended March 31, 2018

Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”) is pleased to announce its financial and operating results for the three and nine months’ period ended March 31, 2018. Highlights Nine-month sales...

May 25, 2018 08:22 am ET

Relevium Appoints New CFO to Drive Performance

Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has appointed Mr. Faycal Salek CPA, CA as the Chief Financial Officer of the Company effective immediately. Mr. Salek is...

May 17, 2018 08:00 am ET

Relevium Engages PipeDreemz as Lead ACMPR Consultant for Biocannabix

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has engaged PipeDreemz as lead consultant (the “Consultant”) for the Biocannabix Health Corp (“BHC”) ACMPR applications to...

May 03, 2018 09:02 am ET

Relevium Launches Bioganix® on Walmart.com

Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it has received approval to sell its biggest mover Bioganix® products on Walmart.com. Highlights New and diverse...

Apr 30, 2018 11:20 am ET

Relevium Announces Agreement with Neptune Wellness for MaxSimil®

MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:RLV), (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the signing of a product development, supply and commercialization agreement with Neptune Wellness Solutions (TSX:NEPT) (NASDAQ:NEPT) for...

Apr 26, 2018 08:58 am ET

Relevium Creates Cannabis Brands for North-American Market

MONTREAL, April 26, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of its two first cannabis brands, LeefyLyfe and Biocannabix offering cannabis products in the North-American and European...

Apr 19, 2018 10:14 am ET

Relevium Creates Biocannabix Subsidiary and Targets Legal Cannabis Business

MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX VENTURE:RLV) (OTCQB:RLLVF) (FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of Biocannabix Health Corporation (the “Subsidiary” or “BHC”), a Canadian wholly owned subsidiary structured to...

Apr 05, 2018 01:37 pm ET

Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has started the process of establishing European presence for the new Bioganix(R) brand in partnership with several online partners, including Amazon. Management will be doing an initial launch of eight best selling products, which will be live online on the week of the May 21, 2018 with full marketing launch by mid summer.

Apr 05, 2018 01:37 pm ET

Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)

Apr 03, 2018 09:00 am ET

Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018.

Apr 03, 2018 08:58 am ET

Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018. The reported record high of 16,549 units,...

Mar 29, 2018 10:26 am ET

Relevium Launches New Bioganix Brand Architecture

Mar 29, 2018 10:26 am ET

Relevium Launches New Bioganix Brand Architecture

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key branding points of Credibility, Quality and Trust. The Company will be rolling out its new brand and new packaging immediately.

Mar 13, 2018 09:00 am ET

Relevium Announces Initial Launch of Hempco's PlanetHemp® in the USA

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) ("Relevium") and Hempco Food and Fiber Inc (TSX VENTURE: HEMP) ('Hempco') are pleased to announce the launch of five PlanetHemp(R) products in the U.S., which are expected to be live the week of March 19, 2018.

Mar 13, 2018 08:58 am ET

Relevium Announces Initial Launch of Hempco's PlanetHemp® in the USA

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) ("Relevium") and Hempco Food and Fiber Inc (TSX VENTURE:HEMP) ('Hempco') are pleased to announce the launch of five PlanetHemp® products in the U.S., which are...

Mar 07, 2018 10:58 am ET

Relevium Launches New Aloe Vera Based Products

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has entered into an agreement with Curaçao Ecocity Projects N.V. to conduct a soft launch of an exclusive...

Mar 07, 2018 10:58 am ET

Relevium Launches New Aloe Vera Based Products

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has entered into an agreement with Curacao Ecocity Projects N.V. to conduct a soft launch of an exclusive line of Aloe Vera based supplements and skin care products under the Bioganix(R) brand.

Mar 05, 2018 11:11 am ET

Relevium Appoints Mr. Didier Martin as Blockchain Lead Expert

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF) and (FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has appointed Mr. Didier Martin as special advisor and project leader for the Company's current and future...

Mar 05, 2018 11:11 am ET

Relevium Appoints Mr. Didier Martin as Blockchain Lead Expert

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF) and (FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has appointed Mr. Didier Martin as special advisor and project leader for the Company's current and future Blockchain projects.

Mar 02, 2018 11:08 am ET

Relevium Provides H2 Guidance for Bioganix, Acquisitions and Legal Hemp Derivatives

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide guidance on its strategy for its core e-commerce business for the second half of fiscal year ending June 30, 2018.

Mar 02, 2018 11:08 am ET

Relevium Provides H2 Guidance for Bioganix, Acquisitions and Legal Hemp Derivatives

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide guidance on its strategy for its core e-commerce business for the second half of fiscal year ending June 30, 2018....

Mar 01, 2018 04:01 pm ET

Relevium Announces Revenue of $2.1M for the Six-Month Period Ended December 31, 2017

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the results for the three and six months ended December 31, 2017. Financial and Operating Highlights for the...

Mar 01, 2018 04:01 pm ET

Relevium Announces Revenue of $2.1M for the Six-Month Period Ended December 31, 2017

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the results for the three and six months ended December 31, 2017.

Feb 23, 2018 12:37 pm ET

Relevium Clarifies Operational Update

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide further clarifications on its press release from earlier today.

Feb 23, 2018 12:37 pm ET

Relevium Clarifies Operational Update

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide further clarifications on its press release from earlier today. The Company has received several requests...

Feb 23, 2018 09:00 am ET

Relevium Operational Update and Investments for Financial H1 2018

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017).

Feb 23, 2018 08:58 am ET

Relevium Operational Update and Investments for Financial H1 2018

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017). Aurelio...

Feb 20, 2018 10:56 am ET

Relevium Commences Trading on OTCQB

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF

Feb 20, 2018 10:56 am ET

Relevium Commences Trading on OTCQB

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF Aurelio Useche, President and CEO...

Feb 16, 2018 03:38 pm ET

Relevium Announces 2018 AGM Results

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montréal, Canada (the "AGM")....

Feb 16, 2018 03:38 pm ET

Relevium Announces 2018 AGM Results

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montreal, Canada (the "AGM").

Feb 05, 2018 09:47 am ET

Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement.

Feb 05, 2018 09:47 am ET

Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate...

Jan 18, 2018 03:14 pm ET

Relevium to Host Webcast to Discuss Previously Announced Blockchain Project

Relevium Technologies Inc. (TSX VENTURE:RLV)(OTC PINK:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent...

Jan 18, 2018 03:14 pm ET

Relevium to Host Webcast to Discuss Previously Announced Blockchain Project

Relevium Technologies Inc. (TSX VENTURE: RLV)(OTC PINK: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent e-retail platform and artificial intelligence technology stack.

Jan 11, 2018 08:48 am ET

IIROC Trade Resumption - Relevium Technologies Inc

Vancouver, British Columbia--(Newsfile Corp. - January 11, 2018) - Trading resumes in:

Jan 11, 2018 07:54 am ET

IIROC Trading Resumption - PRV.UN; RLV; LMR; UI

VANCOUVER, Jan. 11, 2018 /CNW/ - Trading resumes in:

Jan 11, 2018 07:00 am ET

Relevium Signs JV for E-Commerce AI With Blockchain Technology Integration, Proposes Initial Coin Offering

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the signing of a joint venture agreement ("JV") with Quantomic LLC (the "Parties") for Tagspire, a virtual retail and visual commerce platform.

Jan 11, 2018 06:58 am ET

Relevium Signs JV for E-Commerce AI With Blockchain Technology Integration, Proposes Initial Coin Offering

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the signing of a joint venture agreement ("JV") with Quantomic LLC (the "Parties") for Tagspire, a virtual retail and visual commerce...

Jan 10, 2018 01:54 pm ET

IIROC Trade Halt - Relevium Technologies Inc

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - The following issues have been halted by IIROC:

Jan 10, 2018 12:57 pm ET

IIROC Trading Halt - RLV

VANCOUVER, Jan. 10, 2018 /CNW/ - The following issues have been halted by IIROC:

Jan 08, 2018 02:06 pm ET

Relevium Update On Shares-For-Services Agreement

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") announces that it has issued 38,935 shares today at a deemed price of $0.224733 per share to the Company's Corporate Secretary, Mr. David A. Johnson, pursuant to a shares-for-services agreement disclosed in a company press release dated October 20, 2017. The shares are subject to a four month hold period. Pricing was determined using the VWAP on the close of January 5, 2018, when submission to the TSX Venture Exchange approval was filed.

Jan 08, 2018 02:06 pm ET

Relevium Update On Shares-For-Services Agreement

Dec 22, 2017 04:27 pm ET

Relevium Update on Stock Option Plan and Option Issues

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce that the board of directors passed a resolution concerning changes to the Company's stock option plan presented at the Company's Annual...

Dec 19, 2017 02:19 pm ET

Relevium Update on Big Data / AI and Announces Webcast

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide an update on the Big Data /AI project as announced on September 7, 2017 and hosting of a webcast on December 21, 2017....

Dec 19, 2017 02:18 pm ET

Relevium Update on Big Data / AI and Announces Webcast

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide an update on the Big Data /AI project as announced on September 7, 2017 and hosting of a webcast on December 21, 2017.

Dec 12, 2017 07:00 am ET

Relevium Strengthens its Balance Sheet: Long-term Debt Down by $900,000, Cash Increases by Over $1,100,000

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has strengthened its balance sheet through the partial conversion of debentures into equity, and increased its cash position through the exercise of warrants and options. The Company is also pleased to provide an update on the Non-Binding Letter of Intent ("LOI") announced October 25, 2017.

Dec 12, 2017 06:58 am ET

Relevium Strengthens its Balance Sheet: Long-term Debt Down by $900,000, Cash Increases by Over $1,100,000

Dec 06, 2017 07:00 am ET

Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the signing of an exclusive distribution agreement (the "Agreement") with Tersus Life Sciences for Provinal(R) C16:1n7 a patented, ultra-purified Omega 7 fatty acid blend .

Dec 06, 2017 06:58 am ET

Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the signing of an exclusive distribution agreement (the "Agreement") with Tersus Life Sciences for Provinal® C16:1n7 a...

Nov 30, 2017 12:00 am ET

Relevium Announces First Quarter Results With Revenues of $1.15million and 13% Adjusted EBITDA Margin

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017.

Nov 29, 2017 11:58 pm ET

Relevium Announces First Quarter Results With Revenues of $1.15million and 13% Adjusted EBITDA Margin

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017. Financial Highlights This is the...

Nov 23, 2017 01:16 pm ET

Relevium & HempCo Sign Exclusive Product Agreement for PlanetHemp

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly-traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the signing of an exclusive brand and product assignment with HempCo Canada ("HempCo") for the Planet Hemp brand.

Nov 23, 2017 01:15 pm ET

Relevium & HempCo Sign Exclusive Product Agreement for PlanetHemp

Nov 06, 2017 09:09 am ET

Relevium Drives Top Line Growth for Q1

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce top line growth for Q1 in anticipation of its interim filings.

Nov 06, 2017 09:09 am ET

Relevium Drives Top Line Growth for Q1

Oct 31, 2017 12:01 am ET

Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the filing of the company's Audited Financial Statements and MD&A for the fiscal year ended June 30, 2017 and 2016 on Sedar

Oct 30, 2017 11:59 pm ET

Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016

Oct 27, 2017 03:21 pm ET

Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce a brief operational update on progress and the appointment of a Senior Marketing Officer.

Oct 27, 2017 03:21 pm ET

Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer

Oct 25, 2017 08:30 am ET

Relevium Signs LOI to Acquire Nutraceutical Brand

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and wellness market, is pleased to announce that it has signed a non-binding Letter Of Intent (the "LOI") to acquire an American based nutraceutical brand that sells products direct to consumers primarily through the Amazon.com channel in the Vitamins and Dietary Supplements category. The transaction value is currently estimated

Oct 25, 2017 08:28 am ET

Relevium Signs LOI to Acquire Nutraceutical Brand

Oct 20, 2017 03:34 pm ET

Relevium Changes Auditors and Corporate Update

Oct 20, 2017 03:34 pm ET

Relevium Changes Auditors and Corporate Update

Relevium Technologies Inc. (TSX VENTURE: RLV) and (FRANKFURT: 6BX) (the "Company" or "Relevium") announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company's new auditor (the "Successor Auditor"), replacing Nexia Freedman LLP, Chartered Professional Accountants (the "Former Auditor"). At the request of the Company, the Former Auditor has resigned and the Successor Auditor has been appointed as of the effective date of October 11, 2017.

Sep 28, 2017 08:00 am ET

Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and Biodevas Laboratoires to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to Pet Care owners on a direct to consumer basis. Product and market development initiatives are expected to begin in October of this year with the objective of a preliminary launch by Spring of 2018 as a wholly-owned subsidiary of Relevium.

Sep 28, 2017 07:58 am ET

Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets

Sep 07, 2017 12:00 pm ET

Relevium Launches First Stage Big Data & AI Project and Engages agileDSS Inc.

Sep 07, 2017 11:58 am ET

Relevium Launches First Stage Big Data & AI Project and Engages agileDSS Inc.

Aug 02, 2017 08:00 am ET

Relevium Reports Revenue Growth in the First 50 Days of Business and Guidance Update

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a publicly traded corporation strategically focused on the acquisition of e-retail brands, products and technologies in the health and wellness market is pleased to provide guidance on its strategy and focus for the balance of calendar year 2017.

Aug 02, 2017 07:58 am ET

Relevium Reports Revenue Growth in the First 50 Days of Business and Guidance Update

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a publicly traded corporation strategically focused on the acquisition of e-retail brands, products and technologies in the health and wellness market is...

Jun 22, 2017 10:12 am ET

Relevium Provides Corporate Update and Final Closing of the Equity Financing

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide a corporate update on its recent acquisition of BioGanix and the closing of...

Jun 22, 2017 10:12 am ET

Relevium Provides Corporate Update and Final Closing of the Equity Financing

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide a corporate update on its recent acquisition of BioGanix and the closing of the final tranche o of the equity financing.

Jun 12, 2017 01:18 pm ET

IIROC Trading Resumption - RLV

VANCOUVER, June 12, 2017 /CNW/ - Trading resumes in:

Jun 12, 2017 11:56 am ET

Relevium Completes Acquisition of BioGanix and Initial Closing of Concurrent Debt and Equity Financing

Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has completed the acquisition of all of the business and...

Jun 12, 2017 11:55 am ET

Relevium Completes Acquisition of BioGanix and Initial Closing of Concurrent Debt and Equity Financing

Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has completed the acquisition of all of the business and assets of BioGanix Ltd. as well as the initial closing of its concurrent debt and equity financing.

Jun 06, 2017 06:08 pm ET

IIROC Trading Halt - RLV

VANCOUVER, June 6, 2017 /CNW/ - The following issues have been halted by IIROC:

Ad blocking detected

Relevium Technologies Inc. (V:RLV.H)

Business Focus: Special Foods & Wellbeing Products